Spectrum Pharmaceuticals Announces Authorization Of Stock Repurchase Program up to $100 Million
Spectrum Pharmaceuticals (Nasdaq: SPPI) today announced that the Company's Board of Directors has approved an increase in its stock repurchase program authorizing the repurchase of up to a total of $100 million of the Company's common stock. The Company was previously authorized to repurchase up to $25 million of its stock.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.